Apogee Therapeutics, Inc.APGENASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+109.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
9.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $284.18M | +31.0% |
| 2024 | $216.87M | +133.2% |
| 2023 | $93.00M | +202.7% |
| 2022 | $30.73M | - |